title: Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial:  from statistics to clinical judgment.
authors.forename: Davide
authors.initials: D
authors.lastname: Capodanno
authors.forename: Valeria
authors.initials: V
authors.lastname: Calvi
authors.forename: Corrado
authors.initials: C
authors.lastname: Tamburino
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000401:mortality / Q000628:therapy*; D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000401:mortality; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D000077144:Clopidogrel; D003627:Data Interpretation, Statistical; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke / Q000209:etiology / Q000517:prevention & control; D000077486:Ticagrelor; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine